EDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedema - Concepedia

Concepedia

Publication | Closed Access

EDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedema

140

Citations

9

References

2010

Year

Robyn J. Levy, William R. Lumry, Donald McNeil, H. Henry Li, Marilyn Campion, Patrick T. Horn, William E. Pullman

Annals of Allergy Asthma & Immunology

Subcutaneous Ecallantide TreatmentHereditary AngioedemaAngiologyDermatologyMedicinePhase 3

References

	Year	Citations

Page 1